Rushani Cameron | Medicine and Dentistry | Innovative Research Award

Innovative Research Award

Rushani Cameron
Affiliation SUNY Downstate Health Sciences University, Brooklyn, New York, USA
Country United States
Scopus ID 60539313500
Documents 2
Subject Area Orthopedic Surgery, Sports Medicine, Outcomes Research, Medicine and Dentistry
Event World Science Awards
ORCID 0009-0003-0166-1505

Rushani Cameron
SUNY Downstate Health Sciences University, Brooklyn, New York, USA

Rushani Cameron is a physician-scientist in training whose academic work centers on orthopedic surgery, sports medicine, cartilage restoration, hip preservation, arthroscopy, and clinical outcomes research. As a Doctor of Medicine candidate at SUNY Downstate Health Sciences University, Cameron has developed an active research portfolio through collaborations with NYU Langone Health and Maimonides Medical Center. Her work integrates evidence-based clinical investigation with patient-centered outcome assessment and has resulted in multiple peer-reviewed publications and national scientific presentations.[1]

Abstract

Rushani Cameron has established an emerging academic profile through clinical research in orthopedic surgery and sports medicine. Her investigations evaluate long-term surgical outcomes, graft survivorship, mental health influences on orthopedic recovery, cartilage restoration, and hip preservation. Through collaborations with leading orthopedic researchers, she has contributed to peer-reviewed literature and numerous presentations at internationally recognized conferences, demonstrating a strong commitment to evidence-based clinical research.[2]

Keywords

Orthopedic Surgery, Sports Medicine, Hip Arthroscopy, Cartilage Restoration, Meniscal Allograft Transplantation, Outcomes Research, Orthopedic Research, Medical Education, Clinical Research, Evidence-Based Medicine.

Introduction

Orthopedic surgery increasingly depends upon high-quality clinical evidence to improve patient outcomes and optimize surgical decision-making. Cameron’s academic activities focus on generating clinically relevant evidence addressing sports medicine, hip preservation, cartilage repair, and patient-reported outcomes. Her work reflects interdisciplinary collaboration across academic medical centers and demonstrates an early commitment to translational orthopedic research.[3]

Research Profile

  • Doctor of Medicine Candidate at SUNY Downstate Health Sciences University.
  • Former Orthopedic Research Fellow at NYU Langone Health.
  • Orthopedic Research Scholar at Maimonides Medical Center.
  • Research interests include sports medicine, hip preservation, arthroscopy, cartilage restoration, and clinical outcomes.
  • Recipient of multiple academic honors, including Best Researcher Award, Best Paper Award, and Innovative Research Award.

Research Contributions

Cameron’s research emphasizes long-term evaluation of orthopedic procedures using retrospective cohort studies, registry analyses, and patient-reported outcomes. Her published investigations have examined corticosteroid injections before meniscal transplantation, chondrocyte implantation outcomes, ankle fracture readmissions, posterior tibial slope, and survivorship following meniscal allograft transplantation. Additional ongoing work explores hip arthroscopy, surgical technology, mental health, and cartilage restoration.[4]

Publications

  • Preoperative Intra-Articular Corticosteroid Injection Is Not Associated with Inferior Reoperation or Patient-Reported Outcomes Following Meniscal Allograft Transplantation. DOI: 10.3390/surgeries7020075
  • Patient Comorbidities Drive 90-Day Emergency Department Revisits and Readmissions After Trimalleolar Ankle Fracture ORIF. DOI: 10.5435/JAAOS-D-25-01063
  • Preoperative Corticosteroid Injection and Outcomes Following Chondrocyte Implantation. DOI: 10.3390/surgeries7010040
  • Posterior Tibial Slope and Meniscal Allograft Survivorship. DOI: 10.1002/ksa.70460

Research Impact

The research portfolio demonstrates active participation in clinically meaningful orthopedic investigations addressing patient safety, surgical outcomes, graft survivorship, and long-term functional recovery. Cameron has presented research at major professional organizations including AAOS, AOSSM, ISHA, COS, EOA, OSET, and NMA, illustrating broad dissemination of research findings within the orthopedic community.[5]

Award Suitability

Based on her documented academic record, peer-reviewed publications, leadership activities, and extensive participation in national orthopedic conferences, Rushani Cameron demonstrates characteristics commonly associated with emerging investigator recognition. Her multidisciplinary research, commitment to medical education, and contributions to orthopedic outcomes research support consideration for early-career research recognition within academic medicine.[6]

Conclusion

Rushani Cameron represents an emerging clinician-investigator whose scholarly work spans orthopedic surgery, sports medicine, and outcomes research. Her publication record, conference presentations, leadership roles, and continued engagement in translational orthopedic investigations demonstrate a sustained commitment to advancing evidence-based patient care and medical research.

External Links

References

  1. Elsevier. Scopus Author Details: Rushani Cameron, Author ID 60539313500.
    https://www.scopus.com/authid/detail.uri?authorId=60539313500
  2. Cameron RK et al. Surgeries. 2026.
    https://doi.org/10.3390/surgeries7020075
  3. SUNY Downstate Health Sciences University Curriculum Vitae.
  4. NYU Langone Health Orthopedic Research Portfolio.
  5. American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, Clinical Orthopaedic Society, International Society for Hip Arthroscopy Conference Abstracts.
  6. Curriculum Vitae and documented academic achievements supplied by the researcher.

Muhammad Noman | Health Professions | Innovative Research Award

Innovative Research Award

Muhammad Noman
The University of Faisalabad, Faisalabad, Pakistan
Muhammad Noman
Affiliation The University of Faisalabad
Country Pakistan
Scopus ID 59599793100
Documents 2
Citations 5
h-index 1
Subject Area Microbiology, Hematology, Health Professions
Event World Science Awards

Muhammad Noman is a Pakistani academic and medical laboratory technologist specializing in molecular diagnostics, hematology, microbiology, histopathology, bio-chemistry, clinical pathology, infectious disease surveillance, and laboratory quality management systems. He currently serves as Senior Lecturer in Medical Laboratory Sciences at The University of Faisalabad and has accumulated extensive experience in laboratory diagnostics, biosafety management, and pandemic-related healthcare operations.[1] His professional contributions include academic teaching, molecular diagnostic testing, operation of Biosafety Level-II and Biosafety Level-III laboratories, and participation in public health initiatives related to COVID-19 and infectious disease control.[2]

Abstract

Muhammad Noman has established a multidisciplinary professional profile in medical laboratory sciences through his involvement in molecular diagnostics, infectious disease surveillance, hematology, microbiology, and laboratory biosafety systems. His work spans academic instruction, laboratory management, diagnostic operations, and healthcare research with emphasis on COVID-19, hepatitis C virus prevalence, dengue fever, and thalassemia-related investigations.[3] He has participated in laboratory quality management training programs, biosafety initiatives, and international academic collaborations while contributing to research publications focused on epidemiology and diagnostic methodologies.[4]

Keywords

Medical Laboratory Sciences, Molecular Diagnostics, Hematology, Histopathology, Microbiology, Clinical Pathology, Biosecurity, Biosafety, Infectious Diseases, COVID-19, Laboratory Quality Management, Disease Surveillance, Molecular Epidemiology, Public Health, Healthcare Research.

Introduction

The advancement of medical laboratory sciences has become increasingly important in the detection, monitoring, and prevention of infectious and non-communicable diseases. Professionals working in diagnostic laboratories contribute significantly to healthcare systems by ensuring accurate laboratory analyses, biosafety compliance, and disease surveillance activities.[5] Muhammad Noman has developed professional expertise across several branches of pathology and laboratory sciences, including microbiology, hematology, immunology, molecular biology, and laboratory biosafety systems.

His professional activities include work in Biosafety Level-II and Level-III laboratory environments, COVID-19 PCR testing, blood banking, laboratory quality assurance, and academic teaching. In addition to laboratory diagnostics, he has participated in workshops and professional development activities related to infectious disease management, laboratory risk management, and clinical pathology systems.[5]

Research Profile

Muhammad Noman completed his Master of Science in Medical Laboratory Sciences from Riphah International University Lahore between 2021 and 2023. Prior to this, he obtained a Bachelor of Science (Honours) degree in Medical Laboratory Technology from Government College University Faisalabad. He also completed specialized technical education in operation theater technology and clinical biochemistry.[1]

His professional experience includes appointments as Lecturer in Medical Laboratory Sciences at The University of Faisalabad, Blood Bank Technologist at Mujahid Hospital Faisalabad, Medical Laboratory Technologist at Allied Hospital Faisalabad, and laboratory staff member at Al-Khidmat Diagnostic Center. His work has involved laboratory diagnostics, infectious disease testing, laboratory supervision, and operation of clinical laboratory systems during pandemic response activities.[2]

Research Contributions

Muhammad Noman’s research activities focus on laboratory diagnostics, epidemiology, and public health-related investigations. His scholarly contributions include studies on hepatitis C virus prevalence, COVID-19 diagnostic methodologies, dengue fever hematological profiling, and mortality-associated factors in thalassemia patients.[3]

He has also contributed to literature associated with CRISPR/Cas technologies and molecular diagnostic approaches in modern biomedical sciences. His involvement in laboratory biosafety and quality management programs demonstrates integration between academic research and clinical laboratory operations.[2]

Publications

  1. Arif, A., Noor-ul-Ain, Munir, A., Noman, M., Munawar, N., Abdelsalam, K., Qari, S. H., & Ahmad, A. (2023). Global Patent Landscape in CRISPR/Cas. In CRISPRized Horticulture Crops, Elsevier.
  2. Noman et al. (2023). Demographic Insights into Hepatitis-C Virus Prevalence among Internally Displaced Persons (IDPs) and Native Populations of Punjab, Pakistan. The Research of Medical Review.
  3. Noman et al. (2025). Role of Immunochromatographic Techniques in the Diagnosis of COVID-19. Indus Journal of Bioscience Research.
  4. Noman et al. (2025). Differential Diagnosis of Different Etiological Markers of COVID-19 among Lab Personals. The Research of Medical Science Review.
  5. Noman et al. (2025). Clinical and Hematological Profiling of Dengue Fever: Impact of Age, Gender, and Comorbidities on Disease Severity. Indus Journal of Bioscience Research.
  6. Noman et al. (2025). Investigate the Mortality, Morbidity and Factors Associated in Thalassemia Patients in Faisalabad, Pakistan. Indus Journal of Bioscience Research.

Research Impact

The research and laboratory activities undertaken by Muhammad Noman contribute to healthcare diagnostics, biosafety awareness, and disease surveillance initiatives within Pakistan’s healthcare and academic sectors. His involvement in molecular diagnostics and infectious disease testing has supported laboratory preparedness during COVID-19 response activities.[3]

Through academic instruction and laboratory supervision, he has participated in the training and development of medical laboratory technology students while maintaining involvement in quality assurance and biosafety systems. His work reflects integration between laboratory sciences, public health surveillance, and healthcare education.[1]

Award Suitability

Muhammad Noman demonstrates qualifications relevant to recognition in the field of medical laboratory sciences and healthcare diagnostics due to his combined contributions to laboratory management, molecular diagnostics, biosafety operations, and academic instruction. His professional engagement with BSL-II and BSL-III laboratory systems, participation in COVID-19 testing operations, and research publications in infectious disease diagnostics indicate substantial involvement in healthcare laboratory sciences.[5]

His participation in national and international workshops, laboratory quality management training, and professional memberships further reflects ongoing engagement with biomedical and laboratory science advancements. These contributions align with the objectives of academic and healthcare research recognition programs.[4]

Conclusion

Muhammad Noman’s academic and professional profile reflects interdisciplinary involvement in medical laboratory sciences, molecular diagnostics, infectious disease surveillance, and laboratory biosafety systems. His combination of clinical laboratory experience, research participation, and academic teaching contributes to the advancement of diagnostic healthcare practices and laboratory sciences education in Pakistan.[2] His continued contributions to research, laboratory management, and healthcare diagnostics support his recognition within biomedical and medical laboratory science communities.

References

  1. Professional academic curriculum vitae and educational background of Muhammad Noman, including qualifications in Medical Laboratory Sciences and Medical Laboratory Technology.
  2. Professional experience records including appointments at The University of Faisalabad, Allied Hospital Faisalabad, Mujahid Hospital, and Al-Khidmat Diagnostic Center.
  3. Research publications associated with infectious disease diagnostics, COVID-19 investigations, dengue fever profiling, and thalassemia-related studies.
  4. Professional certifications and memberships related to biosafety, laboratory quality management systems, and molecular diagnostics training.
  5. World Health Organization. (n.d.). Laboratory biosafety guidance related to infectious diseases and diagnostic systems.

Antra Chaudhary | Pharmaceutical Science | Young Scientist Award

Young Scientist Award

Antra Chaudhary,
Jamia Hamdard University, New Delhi, India.

Antra Chaudhary
Affiliation Jamia Hamdard University
Country India
Scopus ID 57406830100
Documents 10
Citations 119
h-index 5
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event World Science Awards
ORCID 0009-0006-9003-5566

Antra Chaudhary is an Indian pharmacology researcher and doctoral scholar recognized for her contributions to bone pharmacology, oxidative stress, inflammatory disorders, and neuroprotection research. Her academic work has focused extensively on translational pharmacological approaches involving medicinal plants, osteoporosis therapeutics, neuroinflammation, stem cell-based therapies, and molecular signaling pathways associated with disease progression and tissue protection.[1] She is currently pursuing doctoral research at Jamia Hamdard University under the supervision of Prof. Divya Vohora, where her investigations explore the therapeutic potential of natural compounds against glucocorticoid-induced bone damage and postmenopausal osteoporosis.[2]

Abstract

This academic article presents a scholarly overview of the research contributions, scientific achievements, and professional development of Antra Chaudhary, a pharmacology researcher specializing in bone pharmacology, oxidative stress, inflammatory disorders, and neuroprotection. Her research has contributed to understanding molecular signaling pathways associated with osteoporosis, ischemic stroke, rheumatoid arthritis, and mitochondrial dysfunction. Through interdisciplinary pharmacological investigations involving in vitro and in vivo models, her work has emphasized translational therapeutic strategies and the use of bioactive compounds for disease modulation.[3] The article further documents her academic qualifications, awards, technical expertise, scientific publications, and suitability for academic recognition in the field of pharmacology and biomedical sciences.

Keywords

Bone Pharmacology, Oxidative Stress, Osteoporosis, Pharmacology, Neuroprotection, Medicinal Plants, Inflammatory Diseases, Stem Cell Therapy, Molecular Pharmacology, Translational Research, Rheumatoid Arthritis, Glucocorticoid-Induced Bone Damage, Pharmacodynamics, Biomedical Sciences.

Introduction

Contemporary pharmacological research increasingly emphasizes translational approaches that integrate molecular biology, therapeutic intervention, and clinical applicability. Researchers in pharmacology are actively investigating novel compounds and signaling pathways to address chronic diseases, neurodegeneration, inflammatory disorders, and metabolic dysfunctions.[4] Within this scientific landscape, Antra Chaudhary has contributed to emerging research areas involving osteoporosis therapeutics, oxidative stress modulation, neuroinflammation, and medicinal plant-based pharmacological interventions.

Her academic journey reflects a progression through pharmaceutical sciences and toxicology training, supported by competitive national examinations including GPAT and NIPER-JEE. She has participated in multidisciplinary research projects and advanced laboratory investigations utilizing molecular, histological, and imaging-based techniques for experimental pharmacology studies.[5]

Research Profile

Antra Chaudhary completed her Master of Science in Pharmacology and Toxicology from the National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, where she worked on medicinal plant extracts from North-East India for inflammatory disease research. Her doctoral research at Jamia Hamdard University focuses on bone pharmacology and oxidative stress biology under the supervision of Prof. Divya Vohora.[2]

Her technical expertise encompasses a broad range of experimental methodologies, including Western blotting, RT-PCR, immunohistochemistry, fluorescence microscopy, micro-computed tomography, small animal imaging, and cell culture systems. She has also demonstrated competence in pharmacological data analysis using GraphPad Prism and image analysis software.[3]

  • DST WISE KIRAN Fellow for doctoral research in Life Sciences.
  • Qualified GPAT and NIPER-JEE examinations with competitive national rankings.
  • Recipient of the Young Investigator Award 2025 at IPC-IPSCON 2025.
  • Contributor to peer-reviewed journals in pharmacology and neuroscience.

Research Contributions

The scientific contributions of Antra Chaudhary span multiple pharmacological domains, including neuroprotection, osteoporosis, inflammatory signaling, and mitochondrial biology. Her collaborative studies have investigated the role of cardiolipin-mediated mitochondrial protection in ischemic stroke and the therapeutic implications of stem cell-mediated inflammasome modulation.[1]

Her work on bone-targeted daidzein-loaded hydroxyapatite nanoparticles evaluated osteogenic potential and pharmacodynamic activity in postmenopausal osteoporosis models, highlighting nanotechnology-assisted therapeutic delivery systems.[8] Additionally, she contributed to research exploring TLR4/NF-κB and Keap1/Nrf2 signaling pathways in rheumatoid arthritis using perillyl alcohol interventions.[2]

Her review publications further discuss CRISPR/Cas9 technologies in neurological disorders, drug repurposing strategies for stroke intervention, and glial cell responses in neurodegenerative conditions.[5]

Publications

Selected Research Articles

  1. Gautam N, Sharma P, Chaudhary A, et al. Investigating the osteogenic potential of bone-targeted daidzein loaded hydroxyapatite nanoparticles for postmenopausal osteoporosis. Journal of Drug Targeting, 2025.
  2. Sarmah D, Sarkar A, Datta A, et al. Cardiolipin-mediated alleviation of mitochondrial dysfunction is a neuroprotective effect of statin in ischemic stroke. ACS Chemical Neuroscience, 2023.
  3. Puppala ER, Jain S, Saha P, et al. Perillyl alcohol attenuates rheumatoid arthritis via regulating TLR4/NF-κB and Keap1/Nrf2 signaling pathways. Phytomedicine, 2022.

Review Articles

  • Advancement in CRISPR/Cas9 technology to better understand and treat neurological disorders.
  • Drug repurposing for stroke intervention.
  • Glial cells response in stroke.

Research Impact

The research contributions of Antra Chaudhary demonstrate interdisciplinary relevance across pharmacology, neuroscience, and biomedical sciences. Her publications address clinically significant challenges associated with osteoporosis, ischemic stroke, inflammatory diseases, and oxidative stress-mediated tissue injury.[11]

Her collaborative work in molecular pharmacology and translational therapeutics contributes to ongoing scientific efforts aimed at developing safer and more effective treatment strategies. The integration of medicinal plant research, nanotechnology-based drug delivery systems, and cellular signaling investigations highlights the translational significance of her scientific profile.[2]

Award Suitability

Antra Chaudhary’s academic profile reflects sustained engagement in experimental pharmacology, translational biomedical research, and scientific dissemination through peer-reviewed publications and conference presentations. Her recognition through the Young Investigator Award at IPC-IPSCON 2025 further demonstrates professional acknowledgment of her contributions within the pharmacological research community.[3]

Her expertise in advanced laboratory techniques, coupled with her publication record and participation in international scientific activities, supports her suitability for academic recognition in the field of pharmacology and bone research. The interdisciplinary scope of her work aligns with contemporary priorities in therapeutic innovation and disease prevention.

Conclusion

Antra Chaudhary represents an emerging researcher in pharmacology whose scientific activities encompass bone pharmacology, oxidative stress biology, neuroprotection, and translational therapeutics. Through experimental research, scholarly publications, and active participation in scientific conferences, she has contributed to advancing knowledge in multiple biomedical domains. Her work continues to support the development of innovative therapeutic approaches aimed at improving disease management and bone health outcomes.[1]

References

  1. Jamia Hamdard University. (2026). Doctoral Research Profile of Antra Chaudhary.
  2. Jamia Hamdard University. (2026). Bone Pharmacology and Oxidative Stress Research Program.
  3. Elsevier. (2025). Pharmacological approaches in osteoporosis and translational therapeutics.
  4. Drug Discovery Today. (2022). Drug repurposing for stroke intervention.
    https://doi.org/10.1016/j.drudis.2022.03.014
  5. National Institute of Pharmaceutical Education and Research. (2020). MS Research Project Documentation.

Áron Mészáros | Health Professions | Research Excellence Award

Mr. Áron Mészáros | Health Professions | Research Excellence Award

Hungarian University of Sport Science | Hungary

Mr. Áron Gergely Mészáros is a Hungarian strength and conditioning specialist and researcher with extensive experience in elite basketball performance and sports science. With a professional background as a former first-division basketball player, he has transitioned into high-level coaching and diagnostics, contributing to national teams and leading academies, including the Hungarian Basketball Federation and Vasas Basketball Academy. His expertise spans movement quality assessment, sport-specific performance testing, injury prevention, and load monitoring using advanced technologies such as VO₂ max analysis, lactate testing, and LPS systems. Mészáros has authored multiple peer-reviewed publications in international journals, focusing on youth athlete development and performance analytics. His work supports evidence-based training practices and contributes significantly to athlete health, performance optimization, and the advancement of sports science methodologies globally.

Citation Metrics (Scopus)

3
2
1
0

Citations
1

h-index
1

Documents
2

Citations

h-index

Documents

Featured Publications

Eniko Nemes-Nagy | Health Professions | Research Excellence Award

Assoc. Prof. Dr. Eniko Nemes-Nagy | Health Professions | Research Excellence Award

George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures | Romania

Assoc. Prof. Dr. Nemes-Nagy Enikő is an Associate Professor in the Department of Chemistry and Medical Biochemistry at the “George Emil Palade” University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, Romania, and a senior laboratory specialist physician. Her academic and clinical expertise lies in medical biochemistry and laboratory medicine, with a primary research focus on oxidative stress in chronic diseases, including diabetes mellitus, hypertension, and obesity. She has authored over 62 full-length peer-reviewed scientific articles published in national and international indexed journals, with a Hirsch index of 7, and has contributed 245 conference abstracts, many of which have received awards. Dr. Nemes-Nagy is also the first author of major biochemistry textbooks and multiple international book chapters. Through interdisciplinary collaborations, student research supervision, and clinical diagnostics, her work has contributed to improved laboratory practices and evidence-based management of chronic metabolic diseases, demonstrating significant academic and societal impact.

Citation Metrics (Scopus)

100
50
10
5

Citations
174
h-index
7
Documents
32

Citations

h-index

Documents

Featured Publications

Nemes-Nagy, Eniko, et al. (2024). Comparative analysis of paraclinical parameters in the assessment of osteoporosis: an integrative approach. Balneo and PRM Research Journal. (Open Access)
Nemes-Nagy, Eniko, et al. (2024). The Predictive Role of Inflammatory Biomarkers and Their Correlation with the Biochemical Profile in Patients with Vasculopathy Undergoing Surgery. International Journal of Molecular Sciences. (Open Access)
Nemes-Nagy, Eniko, et al. (2024). Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy. Review Article · International Journal of Molecular Sciences.

Turkan Mutlu Yar | Medicine and Dentistry | Research Excellence Award

Assist. Prof. Dr. Turkan Mutlu Yar | Medicine and Dentistry | Research Excellence Award

Ordu University Faculty of Medicine | Turkey

Dr. Turkan Mutlu Yar is a dedicated Doctor Ogretim Uyesi in the Department of Medical Parasitology at Ordu University, Faculty of Medicine, where she has been contributing to academic research, teaching, and diagnostics since 2023. She completed her PhD in Parasitology at İnönü University in 2015, with a thesis focused on the effectiveness of PCR in diagnosing Trichomonas infections in male patients. Her academic background also includes a thesis-based Master’s degree in Parasitology, a non-thesis Master’s degree in Biology Teaching, and a Bachelor’s degree in Biology from Fırat University. Dr. Yar’s research expertise spans intestinal parasites, cystic echinococcosis, trichomoniasis, zoonotic parasitic diseases, diagnostic molecular methods, and machine learning applications in parasitology. She has authored numerous peer-reviewed articles in international journals, including studies on Helicobacter pylori, Toxoplasma gondii, Toxocara species, and intestinal parasite prevalence in clinical and community settings. Her collaborative work also explores the antiparasitic effects of plant extracts, decision tree algorithms for disease severity, and risk factor modeling for parasitic infections. In addition, she has contributed multiple book chapters on parasitic diseases, zoonotic infections, liver trematodes, free-living amoebae, and hospital-acquired parasitic pathogens.

Citation Metrics (Scopus)

4
3
2
1
0

Citations
3

Documents
3

h-index
1

Citations

Documents

h-index

Featured Publications

 

Peijie He | Medicine and Dentistry | Innovation Excellence Award

Prof. Dr. Peijie He | Medicine and Dentistry | Innovation Excellence Award

ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

Professor Peijie He, MD, PhD, is a senior surgeon, clinician-scientist, and academic leader in laryngology and head & neck surgery at the Eye and ENT Hospital of Fudan University, Shanghai. As Chief Physician of the Division of Laryngology, his career integrates advanced clinical practice, translational research, and postgraduate medical education, with a sustained focus on function-preserving treatment strategies for laryngeal and hypopharyngeal diseases. His academic training spans China and South Korea, combining clinical otolaryngology with laser medicine and photodynamic therapy, which has shaped his distinctive interdisciplinary research profile. Professor He has made substantial contributions to minimally invasive laryngeal surgery, phonosurgery, and laser-based therapies, particularly the clinical application of CO₂ and KTP lasers, photodynamic therapy, and office-based interventions for vocal fold leukoplakia, papillomatosis, hemangioma, and early-stage laryngeal carcinoma. His work bridges clinical innovation with mechanistic research, elucidating oxidative stress, ROS-mediated pathways, and apoptosis mechanisms in laryngeal cancer cells, thereby strengthening the scientific foundation of modern laryngological treatments. He has authored and co-authored over 30 peer-reviewed international publications in leading journals such as The Laryngoscope, Journal of Voice, European Archives of Oto-Rhino-Laryngology, Lasers in Medical Science, and Oncology Letters, with multiple papers as corresponding author. His research is frequently cited and widely recognized within the otolaryngology community. Professor He has served as Principal Investigator on multiple competitive grants, including projects funded by the National Natural Science Foundation of China and the Shanghai Municipal Health Commission, supporting both basic and clinically translational research.

Citation Metrics (Scopus)
600
500
300

100

Citations
602
Documents
52
h-index
14

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Gianna Dipalma | Medicine and Dentistry | Research Excellence Award

Prof. Dr. Gianna Dipalma | Medicine and Dentistry | Research Excellence Award

University of Bari “Aldo Moro” – University Hospital “Policlinico di Bari” | Italy

Prof. Gianna DiPalma is an accomplished clinician-scientist and academic specializing in dentistry, oral surgery, orthodontics, and regenerative medicine. With dual qualifications in Dentistry (DDS, 2000) and Medicine and Surgery (MD, 2020) from the University of Bari “Aldo Moro,” she has established a distinguished career bridging clinical practice, scientific innovation, and higher education. She further completed an international PhD program in Clinical Dentistry, conducted in collaboration with New York University (USA) and the Eastman Dental Institute (UK), followed by advanced postgraduate training in implant prosthodontics and oral surgical specialization. Her academic trajectory includes an international doctoral fellowship at the University of Lyon, France, reinforcing her international scientific profile. Prof. DiPalma has contributed extensively to oral health sciences, with research spanning regenerative dentistry, biomaterials, implantology, growth factor–based tissue repair, pediatric dentistry, and digital orthodontics. She has authored scientific publications, book chapters, and conference works, and serves as a reviewer and guest editor for internationally indexed journals, including Scopus- and PubMed-listed platforms. Her research involvement includes participation in competitive national and international projects, particularly those focusing on tissue engineering, stem cells, and translational dentistry. Her work demonstrates significant interdisciplinary relevance across dental medicine, biomedical engineering, and clinical innovation. Throughout her career, she has received more than 30 national and international awards recognizing academic merit, research contribution, and innovation in clinical dentistry. She has also contributed to the advancement of dental education through extensive teaching roles, postgraduate training supervision, and invited lectures across Europe and beyond. Prof. DiPalma’s contributions continue to support evidence-based innovations that improve patient care, guide clinical protocols, and enhance the global development of regenerative and digital dental sciences. Her academic trajectory reflects sustained research productivity, international collaboration, and a growing societal impact within the fields of oral health and medical sciences.

Profiles: Scopus | ORCID

Featured Publications

Buthelezi, K., Kibirige, D. M. K., & Buthelezi-Dube, N. N. (2025). The evolution of methods and tools used to assess soil health indicators: A scoping review. SSRN.

Buthelezi-Dube, N. N., & Sithole, Z. (2025). Acidification-driven soil phosphorus fractionation following long-term fertilization and cessation at Ukulinga mesic grassland in South Africa. Scientific Reports.

Buthelezi, K., & Buthelezi-Dube, N. (2025). Long-term effects of nitrogen and lime application on plant–microbial interactions and soil carbon stability in a semi-arid grassland. Plants.

Leshalagae, M., & Buthelezi-Dube, N. N. (2023). Impact of topsoil mining for unfired mudbricks on soil quality in eastern KwaZulu-Natal, South Africa. Land Degradation & Development.

Vilakazi, S. P., Muchaonyerwa, P., & Buthelezi-Dube, N. N. (2023). Characteristics and liming potential of biochar types from potato waste and pine-bark. PLOS ONE

Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Mrs. Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Fondation Adolphe de Rothschild Hospital | France

Dr. Aurore Sajust de Bergues de Escalup is a radiology resident specializing in advanced neuroimaging, thoracic imaging, and musculoskeletal diagnostic modalities, with a growing research portfolio in artificial intelligence–enhanced medical imaging. She is currently completing the advanced phase of her radiology residency at the Hôpital Fondation Adolphe de Rothschild, focusing on neuroradiology and head-and-neck imaging, while simultaneously advancing her research interests in biomedical image analysis and quantitative MRI. Dr. Sajust de Bergues de Escalup holds a Master’s degree in Biomedical Engineering (BioImaging Specialization), awarded with honors, and completed at the PARCC laboratory (Inserm UMR 970). She was awarded the Année Recherche scholarship (ARS), supporting her contributions to translational imaging research. Her academic foundation includes competitive rankings in French national medical examinations (PACES rank: 52; ECN rank: 1227) and early international scientific exposure through her participation in the Biomed Research Academy at the University of Pennsylvania. Her recent peer-reviewed publications reflect an interdisciplinary approach combining clinical expertise and innovation. These include studies on synthetic MRI for optic nerve pathology, deep learning–based MRI reconstruction techniques, and CT phenotypes of interstitial lung disease in autoimmune disorders. Collectively, her work contributes to improving diagnostic accuracy, reducing scan times, and advancing precision imaging in ophthalmologic and thoracic conditions. Her collaborations span multiple major French academic hospitals, including Hôpital Robert-Debré, Hôpital Henri-Mondor, Hôpital Bichat, and the Hôpital de la Timone. Fluent in French and English, she has developed both clinical and research experience across pediatric radiology, emergency imaging, cardiothoracic radiology, and uro-gynecological imaging. Her long-term vision is to contribute to the integration of artificial intelligence and quantitative imaging biomarkers to enhance clinical decision-making and improve patient outcomes in neuroradiology and systemic disease evaluation.

Profile: ORCID

Featured Publications

Sajust de Bergues de Escalup, A., Lecler, A., Poirion, É., Papeix, C., Deschamps, R., Milea, D., Savatovsky, J., Duron, L., & O’Shaughnessy, E. (2025). Deep learning-based image reconstruction significantly improves image quality of MRI examinations of the orbit at 3 Tesla. Diagnostic and Interventional Imaging.

Sajust de Bergues de Escalup, A., Duron, L., Koskas, P., Poirion, É., Papeix, C., Deschamps, R., Milea, D., O’Shaughnessy, E., Savatovsky, J., Fournier, L., et al. (2025). Synthetic MRI for detecting abnormal signals in the optic nerves. Investigative Radiology

Bo Wan | Medicine and Dentistry | Best Researcher Award

Dr. Bo Wan | Medicine and Dentistry | Best Researcher Award

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Dr. Bo Wan is an emerging clinician–scientist in the field of ophthalmology, recognized for his strong commitment to advancing clinical practice and research related to myopia, cataract, and retinal disorders. With several years of experience as an ophthalmologist in a leading medical institution, he has developed extensive competence in the diagnosis, management, and surgical treatment of common and complex ocular diseases. His clinical work is characterized by precision, rigorous reasoning, and patient-centered decision-making, contributing to improved visual outcomes and enhanced quality of life for diverse patient populations. In parallel with his clinical responsibilities, Dr. Wan has maintained an active engagement in academic research, focusing on evidence-based approaches to ophthalmic disorders and exploring strategies for disease prevention and early intervention. He has authored 2 scholarly documents, which together have received 19 citations and an h-index of 1, reflecting the early but growing influence of his research contributions. His work demonstrates a consistent interest in the integration of clinical insights with scientific inquiry, and he has collaborated with colleagues across medical and academic settings to advance shared research goals. These collaborations have supported the development of multidisciplinary perspectives that enrich both clinical practice and investigative rigor. Dr. Wan’s scholarly activities reflect a broader commitment to public health and societal benefit. By contributing to improved diagnostic accuracy and more effective therapeutic pathways in ophthalmology, his work supports long-term visual health and addresses the rising global challenges of myopia and age-related ocular diseases. He is dedicated to continuous professional development and intends to expand his research output, strengthen international collaborations, and contribute to high-impact studies that can influence global ophthalmic guidelines and clinical standards. With a strong foundation in clinical practice, disciplined research habits, and a clear vision for future growth, Dr. Bo Wan is well positioned to make meaningful and sustained contributions to ophthalmic science and global eye health.

Profile: Scopus

Featured Publications

  1. (2024). Parallel comparison of ocular metrics in non-human primates with high myopia by LS900, ultrasonography and MRI-based 3D reconstruction. Experimental Eye Research.